The shifting interface between IBS and IBD. (2011)
Attributed to:
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.coph.2011.09.009
PubMed Identifier: 22000604
Publication URI: http://europepmc.org/abstract/MED/22000604
Type: Journal Article/Review
Volume: 11
Parent Publication: Current opinion in pharmacology
Issue: 6
ISSN: 1471-4892